614 related articles for article (PubMed ID: 17699779)
1. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
3. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
Liu W; Ip MM; Podgorsak MB; Das GM
Breast Cancer Res Treat; 2009 May; 115(1):43-50. PubMed ID: 18481172
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
5. HDAC3-ERα Selectively Regulates TNF-α-Induced Apoptotic Cell Death in MCF-7 Human Breast Cancer Cells via the p53 Signaling Pathway.
Park SH; Kim H; Kwak S; Jeong JH; Lee J; Hwang JT; Choi HK; Choi KC
Cells; 2020 May; 9(5):. PubMed ID: 32455774
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
7. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
8. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
9. Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.
Gu G; Barone I; Gelsomino L; Giordano C; Bonofiglio D; Statti G; Menichini F; Catalano S; Andò S
J Cell Physiol; 2012 Oct; 227(10):3363-72. PubMed ID: 22213398
[TBL] [Abstract][Full Text] [Related]
10. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
11. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
12. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.
Jin W; Chen Y; Di GH; Miron P; Hou YF; Gao H; Shao ZM
J Biol Chem; 2008 Oct; 283(44):29671-80. PubMed ID: 18765668
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.
Liu W; Konduri SD; Bansal S; Nayak BK; Rajasekaran SA; Karuppayil SM; Rajasekaran AK; Das GM
J Biol Chem; 2006 Apr; 281(15):9837-40. PubMed ID: 16469747
[TBL] [Abstract][Full Text] [Related]
19. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
20. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
Xia W; Bisi J; Strum J; Liu L; Carrick K; Graham KM; Treece AL; Hardwicke MA; Dush M; Liao Q; Westlund RE; Zhao S; Bacus S; Spector NL
Cancer Res; 2006 Feb; 66(3):1640-7. PubMed ID: 16452223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
